Carlsbad, CA 11/29/16—Thermo Fisher Scientific has agreed to acquire MTI-GlobalStem for an undisclosed amount. MTI-GlobalStem develops and commercializes technology and reagents for applications in cell transfection, neurobiology and stem cell research. “The addition of MTI-GlobalStem’s technology further strengthens Thermo Fisher’s leadership in biosciences, and provides scientists around the world with access to a wider array of advanced research products designed to help accelerate discovery using cell models,” stated Amy Butler, vice president and general manager of Cell Biology at Thermo Fisher. MTI-GlobalStem will join Thermo Fisher’s Life Sciences Solutions segment. 

The acquisition adds to Thermo’s transfection and stem cell reagent offerings. In addition, it brings to Thermo additional expertise in R&D for primary and iPSC-derived cells and related products, as well as an extension of Thermo Fisher’s cell product line to include primary neural cells.